NEWS SCAN: Anthrax vaccine contract, Salmonella in eggs, H5N1 shots in Taiwan, Staph skin infections Federal contract supports more work on adjuvanted anthrax vaccine Emergent BioSolutions Inc. today announced it has won a federal contract worth up to $28.7 million for further development of its "third generation" anthrax vaccine, consisting of the existing product, BioThrax (anthrax vaccine adsorbed), combined with a novel adjuvant called CPG 7909. BioThrax is the only US-licensed anthrax ... [News Source]